Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: Relevance to familial benign hypocalciuric hypercalcaemia type 3

European Journal of Human Genetics

Volumn 18, Issue 4, 2010, Pages 442-447

  Hannan, Fadil M ^a   Nesbit, M Andrew ^a   Turner, Jeremy J O ^a,b   Stacey, Joanna M ^a   Cianferotti, Luisella ^c   Christie, Paul T ^a   Conigrave, Arthur D ^d   Whyte, Michael P ^e,f   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF SYDNEY   (Australia)

^e SHRINERS HOSPITAL FOR CHILDREN   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Linkage; Rearrangement

Indexed keywords

CALCIUM SENSING RECEPTOR;

ARTICLE; CHROMOSOME 19Q; CHROMOSOME 7; CLINICAL ARTICLE; COMPARATIVE GENE MAPPING; FAMILIAL BENIGN HYPOCALCIURIC HYPERCALCEMIA TYPE 3; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC LINKAGE; HUMAN; HYPERCALCEMIA; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ADULT; ANIMALS; CALCIUM; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERCALCEMIA; LINKAGE (GENETICS); MALE; MICE; MICROSATELLITE REPEATS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCIUM-SENSING;

EID: 77949654192     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.161     Document Type: Article

References (39)

1. Chattopadhyay N, Brown EM: Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 2006; 89: 189-202.
2. Thakker RV: Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004; 35: 275-282.
3. Heath 3rd H: Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 1989; 18: 723-740.
4. Pearce SH, Wooding C, Davies M et al: Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 1996; 45: 675-680.
5. Pollak MR, Brown EM, Chou YH et al: Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyper-parathyroidism. Cell 1993; 75: 1297-1303.
6. Chou YH, Brown EM, Levi T et al: The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1992; 1: 295-300.
7. Pearce SH, Bai M, Quinn SJ et al: Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996; 98: 1860-1866.
8. Bjarnadottir TK, Fredriksson R, Schioth HB: The gene repertoire and the common evolutionary history of glutamate, pheromone (V2R), taste(1) and other related G protein-coupled receptors. Gene 2005; 362: 70-84.
9. Hofer AM, Brown EM: Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 2003; 4: 530-538.
10. Pollak MR, Brown EM, Estep HL et al: Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 1994; 8: 303-307.
11. Pearce SH, Williamson C, Kifor O et al: A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996; 335: 1115-1122.
12. Hobson SA, Wright J, Lee F et al: Activation of the MAP kinase cascade by exogenous calcium-sensing receptor. Mol Cell Endocrinol 2003; 200: 189-198.
13. Hannan FM, Nesbit MA, Christie PT et al: Familial isolated primary hyperparathyroid-ism caused by mutations of the MEN1 gene. Nat Clin Pract Endocrinol Metab 2008; 4: 53-58.
14. D'Souza-Li L, Yang B, Canaff L et al: Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 1309-1318.
15. Heath 3rd H, Jackson CE, Otterud B et al: Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 1993; 53: 193-200.
16. McMurtry CT, Schranck FW, Walkenhorst DA et al: Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia. Am J Med 1992; 93: 247-258.
17. Lloyd SE, Pannett AA, Dixon PH et al: Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 1999; 64: 189-195.
18. Trump D, Whyte MP, Wooding C et al: Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 1995; 96: 183-187.
19. Ashworth LK, Batzer MA, Brandriff B et al: An integrated metric physical map of human chromosome 19. Nat Genet 1995; 11: 422-427.
20. Gyapay G, Morissette J, Vignal A et al: The 1993-1994 Genethon human genetic linkage map. Nat Genet 1994; 7: 246-339.
21. Grimwood J, Gordon LA, Olsen A et al: The DNA sequence and biology of human chromosome 19. Nature 2004; 428: 529-535.
22. Flicek P, Aken BL, Beal K et al: Ensembl 2008. Nucleic Acids Res 2008; 36: D707-D714.
23. Wheeler DL, Barrett T, Benson DA et al: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2008; 36: D13-D21.
24. Bowl MR, Nesbit MA, Harding B et al: An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypopar-athyroidism. J Clin Invest 2005; 115: 2822-2831.
25. Parkinson DB, Thakker RV: A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1992; 1: 149-152.
26. Hinson TK, Damodaran TV, Chen J et al: Identification of putative transmembrane receptor sequences homologous to the calcium-sensing G-protein-coupled receptor. Genomics 1997; 45: 279-289.
27. Yang H, Shi P, Zhang YP et al: Composition and evolution of the V2r vomeronasal receptor gene repertoire in mice and rats. Genomics 2005; 86: 306-315.
28. Stubbs L, Carver EA, Shannon ME et al: Detailed comparative map of human chromosome 19q and related regions of the mouse genome. Genomics 1996; 35: 499-508.
29. Sugimura Y, Murase T, Ishizaki S et al: Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats. Endocrinology 2003; 144: 2791-2796.
30. Stitham J, Arehart EJ, Gleim S et al: Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR). Gene 2007; 396: 180-187.
31. Forsberg L, Bjorck E, Hashemi J et al: Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. Eur J Endocrinol 2005; 152: 459-470.
32. Hait NC, Bellamy A, Milstien S et al: Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J Biol Chem 2007; 282: 12058-12065.
33. Carroll K, Gomez C, Shapiro L: Tubby proteins: the plot thickens. Nat Rev Mol Cell Biol 2004; 5: 55-63.
34. Lavoie C, Meerloo T, Lin P et al: Calnuc, an EF-hand Ca(2+)-binding protein, is stored and processed in the Golgi and secreted by the constitutive-like pathway in AtT20 cells. Mol Endocrinol 2002; 16: 2462-2474.
35. Arvanitis DA, Vafiadaki E, Fan GC et al: Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol 2007; 293: H1581-H1589.
36. Tsuji A, Kikuchi Y, Sato Y et al: A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. Biochem J 2006; 396: 51-59.
37. Bouschet T, Martin S, Kanamarlapudi V et al: The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network. J Cell Sci 2007; 120: 2489-2497.
38. Fan S, Meng Q, Laterra JJ et al: Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene 2007; 26: 4774-4796.
39. Marques-Bonet T, Navarro A: Chromosomal rearrangements are associated with higher rates of molecular evolution in mammals. Gene 2005; 353: 147-154.